AI assistant
Sending…
CASTLE BIOSCIENCES INC — Director's Dealing 2021
Jun 14, 2021
32601_dirs_2021-06-14_b592752c-edb8-48a6-882b-6c39ae7b869d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-06-10
Reporting Person: Cole G Bradley (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-10 | Stock option (right to buy) | $71.22 | A | 3379 | Acquired | 2031-06-09 | Common Stock (3379.0) | Direct |
| 2021-06-10 | Restricted Stock Units | $ | A | 830 | Acquired | Common Stock (830.0) | Direct |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2: The RSUs vest in full on the one-year anniversary of the date of grant on June 10, 2022.
More from CASTLE BIOSCIENCES INC
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Jan 22
Director's Dealing
2026
Jan 14